Article - 25/03/2008 A real milestone Somatic cell nuclear transfer or reprogramming of somatic cells into a near embryonic state - it is now expected that stem cell experts rate their findings in the field of stem cell research. What can be called a breakthrough? What is the scientific value?https://www.gesundheitsindustrie-bw.de/en/article/news/a-real-milestone
Article - 24/03/2008 Successful cooperation between science and industry At the recent Science meets Business Day four tandem teams of the German BioValley Platform presented their projects. These will be introduced in two articles. The first article focuses on natural substances with a pharmaceutical potential.https://www.gesundheitsindustrie-bw.de/en/article/news/successful-cooperation-between-science-and-industry
Article - 19/03/2008 Innovendia: Keeping the focus on client requirements The biotechnology sector is growing and new companies have excellent opportunities to establish themselves on the market. Dr. Michael Steinwand explains what companies have to beware.https://www.gesundheitsindustrie-bw.de/en/article/news/innovendia-keeping-the-focus-on-client-requirements
Article - 11/03/2008 Nils Johnsson delivers initial insights Nils Johnssons work focuses on communication research involving living objects. The 48-year-old biochemist is investigating how proteins manage the complicated process of cytokinesis the division of the cell plasma. Thanks to a specific method Johnsson is able to detect when proteins are interacting with each other.https://www.gesundheitsindustrie-bw.de/en/article/news/nils-johnsson-delivers-initial-insights
Article - 04/03/2008 Germany and France: closer cooperation in research The leaders of the two countries research policy groups met in the French capital to discuss strategies on how to cope with challenges that are faced by both countries in the field of research. Several Agreements signed at the end of the Forum are the basis of strategic partnerships.https://www.gesundheitsindustrie-bw.de/en/article/press-release/germany-and-france-closer-cooperation-in-research
Article - 03/03/2008 Genetic engineering in the conflict of contradictions The history of Bt-maize is a strange mix of opportunities risks scientific contradictions market authorisations and recalls. It is also an excellent example of why the public scepticism towards genetically modified organisms GMO is growing.https://www.gesundheitsindustrie-bw.de/en/article/news/genetic-engineering-in-the-conflict-of-contradictions
Article - 28/02/2008 Gilbert Gorr - a great fan of the moss Physcomitrella patens Dr. Gilbert Gorr has been fascinated by the moss Physcomitrella patens for many years in fact it occupies a great deal of his waking moments. The enthusiasm with which the CSO of greenovation Biotech GmbH talks about the key object of his work is both intoxicating and contagious. The latest discovery The moss produces a therapeutic antibody that is far more effective than its predecessors created in animal cell cultures.https://www.gesundheitsindustrie-bw.de/en/article/news/gilbert-gorr-a-great-fan-of-the-moss-physcomitrella-patens
Article - 20/02/2008 Threadworms throughout time Threadworms are versatile research objects and are excellent models for investigating fundamental evolutionary principles. Researchers at the Max Planck Institute for Developmental Biology use the Caenorhabditis and Pristionchus threadworm genera to study the molecular mechanisms of biodiversity.https://www.gesundheitsindustrie-bw.de/en/article/news/threadworms-throughout-time
Article - 15/02/2008 DNA, an eternal mystery Although the biomolecule DNS has provided many explanations and hopeful projections opinions are divided over the question of DNA being the carrier of genetic information. There is a huge need for clarification. Biologists clinicians psychologists lawyers and bioethicists discussed in Tübingen.https://www.gesundheitsindustrie-bw.de/en/article/news/dna-an-eternal-mystery
Article - 11/02/2008 Human clones and reprogrammed skin cell In 1998 James Thomson was the first to generate stem cells from human embryos. BIOPRO will present the new methods in the field of embryonic stem cell research. Stem cell experts regeneration biologists medics and ethicists will explain whether they think that the new methods are useful or not.https://www.gesundheitsindustrie-bw.de/en/article/news/human-clones-and-reprogrammed-skin-cell
Dossier - 01/02/2008 Glycobiotechnology - sugar research is picking up speed Alongside DNA and proteins sugar structures play an important role in cellular transport and communication processes. They are also part of the molecular control and regulation machinery making them of particular interest to biotechnologists. The pharmaceutical industry as well as the food sector and material sciences have realised the potential of sugar structures.https://www.gesundheitsindustrie-bw.de/en/article/dossier/glycobiotechnology-sugar-research-is-picking-up-speed
Article - 30/01/2008 How cells communicate Prof. Valentin Wittmann professor in the Department of Chemistry at the University of Constance is investigating carbohydrates. At present his major area of interest is carbohydrate-RNA and carbohydrate-protein interactions where he is trying to understand the biological functions of complex sugar molecules glycans.https://www.gesundheitsindustrie-bw.de/en/article/news/how-cells-communicate
Article - 29/01/2008 Breakthrough for glycomics New databases and bioinformatic tools provide the field of glycomics with a solid basis for dynamic development in molecular biology and medicine. Willi von der Lieth a researcher from Heidelberg was an important pioneer of glyco-bioinformatics. His sudden death is a great loss for this new scientific field.https://www.gesundheitsindustrie-bw.de/en/article/news/breakthrough-for-glycomics
Article - 28/01/2008 Funding programme "Medical systems biology - MedSys" Proposals must be submitted prior to 7th May 2008.https://www.gesundheitsindustrie-bw.de/en/article/press-release/funding-programme-medical-systems-biology-medsys
Article - 21/01/2008 Research project "Applied Pathogenomics" The deadline for the submission of preproposals is 29th February 2008.https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-project-applied-pathogenomics
Press release - 20/01/2008 Genetic causes and therapy of cardiac insufficiency Since 2001 the Medical University Hospital in Heidelberg has coordinated the Cardiovascular Network within the framework of the National Genome Research Network NGFN which also involves nine other big German university hospitals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/genetic-causes-and-therapy-of-cardiac-insufficiency
Press release - 19/01/2008 New Microbial Genome-to-Array Service Partnering with Prognosys Biosciences febit offers a new Genome-to-Array Service. This Service gives scientists access to the latest technology and know-how in sequencing and microarrays even for DNA where no standard microarrays are available.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-microbial-genome-to-array-service
Article - 02/01/2008 Nele Wellinghausen - the fascination of pathogens Nele Wellinghausen has always been interested in plants and animals. As a teenager she studied ferns and won the German Jugend forscht competition. Nowadays the medical expert carries out research on microorganisms specifically on pathogens that lead to sepsis.https://www.gesundheitsindustrie-bw.de/en/article/news/nele-wellinghausen-the-fascination-of-pathogens